Healius (AU:HLS) — Company Overview, News & Financial Data
Healius Limited provides diverse medical services including pathology and imaging across Australia.

Healius
Healius Limited (ASX:HLS) is an Australian healthcare company that provides a range of medical services, including pathology, imaging, and day hospital services. Healius is one of the largest healthcare companies in Australia and has a strong track record of operational excellence and financial performance. Healius' operations are focused on the provision of high-quality, accessible, and cost-efficient healthcare services. The company has a network of over 1,800 locations and 12,000 employees across Australia. Healius' services are used by over 10 million Australians each year.
Snapshot
Operations
Products and/or services of Healius
- Pathology services: Provides a comprehensive range of pathology services, including blood tests, tissue biopsies, and cytology tests.
- Imaging services: Provides a range of imaging services, including X-ray, ultrasound, CT, MRI, and nuclear medicine.
- Radiation oncology services: Provides radiation therapy treatment for cancer patients.
- Day hospital services: Provides a range of day surgery and day treatment services.
- Medical centre services: Operates a network of medical centres that provide primary healthcare services.
- New cancer treatment services development: Developing new cancer treatment services, such as immunotherapy and proton therapy.
Healius executive team
- Mr. Paul D. Anderson B.Com., C.A.MD, CEO & Director
- Mr. Andrew ThomsonCFO & Company Secretary
- Mr. Puneet Nagi M.B.A.Chief Operating Officer
- Mr. Prasad AravGroup Executive of Digital & Technology and Strategy
- Sharon NgHead of FP&A and Investor Relations
- Ms. Kylie BrownGroup General Counsel, Company Secretary & Chief Risk Officer
- Ms. Paula BaylissGroup Executive of People & Culture
- Mr. John McKechnieAdvisor
- Dr. Phil LucasChief Executive of Lumus Imaging
- Ian McphanChief Operating Officer of Healius Pathology